Clinical care pathways for the treatment of prostate cancer in Queensland, Australia: the ProsCan Study

被引：0
|
作者：
Chambers , S. K. [1 ,2 ,3 ]
Ferguson, M. [1 ]
Nicol, D. [4 ]
Gardiner, R. A. [3 ,5 ]
Aitken, J. [1 ,6 ]
机构：
[1] Canc Council Queensland, Viertel Ctr Res Canc Control, Brisbane, Qld, Australia
[2] Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia
[3] Australian Prostate Canc Collaborat, Brisbane, Qld, Australia
[4] Princess Alexandra Hosp, Dept Urol, Brisbane, Qld 4102, Australia
[5] Univ Queensland, Dept Surg, Brisbane, Qld, Australia
[6] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia
来源：
BJU INTERNATIONAL | 2009年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
064
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [1] Factors associated with diagnostic and treatment intervals for prostate cancer in Queensland, Australia: a large cohort study
    Peter D. Baade
    Robert A. Gardiner
    Megan Ferguson
    Danny R. Youlden
    Joanne F. Aitken
    John Yaxley
    Suzanne K. Chambers
    Cancer Causes & Control, 2012, 23 : 625 - 634
  • [2] Factors associated with diagnostic and treatment intervals for prostate cancer in Queensland, Australia: a large cohort study
    Baade, Peter D.
    Gardiner, Robert A.
    Ferguson, Megan
    Youlden, Danny R.
    Aitken, Joanne F.
    Yaxley, John
    Chambers, Suzanne K.
    CANCER CAUSES & CONTROL, 2012, 23 (04) : 625 - 634
  • [3] FACTORS ASSOCIATED WITH TREATMENT RECEIVED BY MEN DIAGNOSED WITH PROSTATE CANCER IN QUEENSLAND, AUSTRALIA
    Cooperberg, Matthew R.
    BJU INTERNATIONAL, 2012, 110 (11B) : E720 - E720
  • [4] The effect of clinical pathways utilization on total cost of care for the treatment of prostate cancer.
    Sereday, Karen Ann
    Boulware, David C.
    Kailasam, Vasanth
    Shi, JuQing
    Blazevich, Diane L.
    Burkett, Jason M.
    Stewart, Sandra C.
    Pow-Sang, Julio M.
    Johnstone, Peter Anthony
    Rollison, Dana Elise
    Fields, Karen K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
  • [5] Diagnostic and treatment pathways for men with prostate cancer in Queensland: investigating spatial and demographic inequalities
    Peter D Baade
    Joanne F Aitken
    Megan Ferguson
    Robert A Gardiner
    Suzanne K Chambers
    BMC Cancer, 10
  • [6] Diagnostic and treatment pathways for men with prostate cancer in Queensland: investigating spatial and demographic inequalities
    Baade, Peter D.
    Aitken, Joanne F.
    Ferguson, Megan
    Gardiner, Robert A.
    Chambers, Suzanne K.
    BMC CANCER, 2010, 10
  • [7] A novel approach to decision support for men diagnosed with prostate cancer: the proscan study
    Steginga, S. K.
    Clutton, S.
    Gardiner, R. A.
    Nicol, D. L.
    Heathcote, P.
    James, T.
    Wood, G.
    Yaxley, J.
    BJU INTERNATIONAL, 2006, 97 : 1 - 1
  • [8] ProsCan Partners Study: predicting distress and quality of life for partners of men with prostate cancer up to 5 years after treatment
    Chambers, Suzanne
    Hyde, Melissa
    Lepore, Stephen
    Zajdleiwcz, Leah
    Ugalde, Anna
    Occhipinti, Stefano
    Dunn, Jeff
    PSYCHO-ONCOLOGY, 2015, 24 : 45 - 46
  • [9] Role of clinical pathways in health care provision: Focus on cancer treatment
    Kreys, Eugene D.
    Koeller, Jim M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (12) : 1081 - 1085
  • [10] Development and Implementation of a Cancer Quality Index in Queensland, Australia: A Tool for Monitoring Cancer Care
    Walpole, Euan T.
    Theile, David E.
    Philpot, Shoni
    Youl, Philippa H.
    JOURNAL OF ONCOLOGY PRACTICE, 2019, 15 (07) : 416 - +
12345